-
GLT-1 Upregulation Protects the Injured Brain
2026-09-09
A 2025 Biomolecules study identifies a mechanistic link between elevated 2-arachidonoylglycerol, CB1-CREB signaling, reduced astrocytic GLT-1, and secondary neuronal injury after traumatic brain injury. Using pharmacological intervention, behavioral testing, and molecular analyses in mice, the authors show that restoring glutamate transporter function is associated with reduced neuronal apoptosis and improved cognitive performance.
-
Chlorpromazine HCl: Applied Research Workflows
2026-09-09
Chlorpromazine HCl provides a practical way to interrogate dopamine receptor inhibition, inhibitory synaptic signaling, and hypoxia-related neuronal responses. This guide connects dose-controlled neuropharmacology workflows with orthogonal uptake-assay design inspired by magnetic nanoparticle research, while clearly separating validated findings from experimental extensions.
-
3X (DYKDDDDK) Peptide for ERES Assays
2026-09-08
The 3X (DYKDDDDK) Peptide provides a compact, hydrophilic epitope system for interpreting ER exit-site organization. This article connects FLAG-based detection and purification with the cooperative Tango1–Sec16–Sec12 model, emphasizing assay design, controls, and metal-sensitive workflows.
-
JZL184 Workflows for MAGL and Pain Research
2026-09-08
JZL184 provides a controlled way to inhibit MAGL, elevate 2-AG, and test CB1-linked synaptic, pain, and affective mechanisms. This workflow-focused guide connects biochemical target engagement with electrophysiology, LC-MS/MS, and behavioral validation while emphasizing vehicle control and interpretation limits.
-
PID1, Oxysterols, and Macrophage Fate
2026-09-07
The reference study identifies PID1 as an immunometabolic brake in tumor-associated macrophages: its loss increases LDL uptake, cholesterol accumulation, and ROS-dependent production of 5α,6α-epoxycholesterol and 7β-hydroxycholesterol. These oxysterols inhibit mTOR–STAT6–ARG1 signaling, reprogram macrophages toward antitumor activity, and improve CD8+ T cell surveillance, including in combination with 5-fluorouracil.
-
BV6 and the Translational Logic of IAP Antagonism
2026-09-07
BV6 is more than a cytotoxicity reagent: it is a mechanistic probe for testing whether IAP-dependent survival limits apoptosis, radiotherapy response, chemotherapy response, or immune-cell killing. This perspective connects BV6 biology with disciplined assay design, the distinction between apoptosis and necroptosis, and translational decision-making across cancer and endometriosis models.
-
12-O-tetradecanoyl phorbol-13-acetate Workflows
2026-09-05
Build reproducible PKC and ERK/MAPK experiments with TPA using time-resolved stimulation, orthogonal phenotype readouts, and disciplined stock handling. The workflow connects kinase assays, cancer biology, and carefully bounded immune-signaling applications without treating pathway activation as a substitute for mechanistic validation.
-
U3 snoRNA–DDX21 Control of Mitotic Perichromosomal Regions
2026-09-04
This 2024 study shows that U3 snoRNA is an active regulator of mitotic progression rather than a passive chromosome passenger. By defining a reciprocal relationship between U3 snoRNA and the RNA helicase DDX21, the work connects perichromosomal-region organization, RNA mobility, and condensate properties with mitotic control.
-
Graphene FIR Triggers Apoptosis in Melanoma
2026-09-04
A 2025 BMC Cancer study shows that graphene-mediated far-infrared radiation suppresses B16F10 melanoma growth through coordinated apoptosis, G0/G1 arrest, and altered hypoxia-related signaling. Pharmacological rescue with Z-DEVD-FMK and Z-LEHD-FMK supports contributions from caspase-3 and caspase-9 signaling, while the combined in vitro, transcriptomic, and syngeneic-mouse design provides a useful framework for mechanism-focused melanoma research.
-
Spirocyclic POM Analogues Target MmpL3 in TB
2026-09-03
This 2024 study developed spirocyclic phenyl oxazole methyl analogues and identified compound 5c as a potent inhibitor of Mycobacterium tuberculosis, including drug-resistant clinical isolates. Phenotypic screening, spontaneous mutant generation, and docking linked activity to the essential transporter MmpL3, providing a useful framework for early anti-tubercular lead discovery.
-
0.4% Trypan Blue Solution: Practical QC Guide
2026-09-03
0.4% Trypan Blue Solution supports rapid cell viability measurement, live/dead cell discrimination, and cell counting by staining dead or membrane-damaged cells blue. It is intended for controlled research workflows such as cell culture and cytotoxicity assays, but not for diagnostic, clinical, or medical use.
-
CpAdhE as an Antiparasitic Drug Target
2026-09-02
A 2024 study characterized the bacterial-type bifunctional aldehyde/alcohol dehydrogenase CpAdhE in Cryptosporidium parvum and connected enzyme inhibition with antiparasitic activity in cell culture. Screening identified antifungal imidazoles as lower-micromolar inhibitors, providing a target-to-cell validation framework while leaving selectivity, target engagement, and in vivo efficacy for future investigation.
-
CUDC-907 Dual PI3K/HDAC Assay Guide
2026-09-02
CUDC-907 (SKU A4097) provides a research starting point for simultaneous PI3K and HDAC pathway perturbation in cancer cell assays. It should be used in controlled in vitro workflows with solvent, exposure, and assay-specific controls, not for diagnostic, therapeutic, or clinical applications.
-
ROS-Degradable LNPs for Tumor-Selective mRNA Delivery
2026-09-01
The reference study developed a combinatorial library of thioketal-containing, ROS-degradable lipid nanoparticles and identified BAmP-TK-12 as a preferential mRNA delivery vehicle for tumor cells. Its delivery of DUF5-encoding mRNA depleted mutant RAS and produced stronger antitumor activity than a small-molecule RAS inhibitor, while also highlighting the importance of lipid pKa and intracellular degradation.
-
Polymyxin B Sulfate: Mechanism and Research Uses
2026-09-01
Polymyxin B sulfate is a cationic polypeptide antibiotic used in Gram-negative bacterial infection research. Its membrane-disrupting activity, immunomodulatory observations, and defined handling parameters support studies of multidrug resistance, dendritic cell maturation assays, and sepsis and bacteremia models.